Drugs & Targets FDA approves first companion diagnostic for lung cancer drug November 22, 2024Vol.50 No.44
Drugs & Targets CHMP issues positive opinion of Sarclisa for transplant-ineligible newly diagnosed MM November 22, 2024Vol.50 No.44
Drugs & Targets EC approves of Elahere for treatment of platinum-resistant ovarian cancer November 22, 2024Vol.50 No.44
Drugs & Targets LINDIS Biotech signs licensing agreement with Pharmanovia for the commercialization of catumaxomab November 22, 2024Vol.50 No.44
Drugs & Targets Sheba Medical Center, Roche collaborate to transform NSCLC diagnostics with AI-powered digital pathology November 22, 2024Vol.50 No.44
Drugs & Targets Immunai to collaborate with Teva to enhance clinical decision making in immuno-oncology clinical trials November 22, 2024Vol.50 No.44
Drugs & Targets FDA approves Aucatzyl for adults with r/r B-cell precursor ALL November 15, 2024Vol.50 No.43
Drugs & Targets Tempus, Flatiron collaborate to expand point of care through OncoEMR integration November 15, 2024Vol.50 No.43
